These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27253733)

  • 1. Results from an external proficiency testing program: 11 years of molecular genetics testing for myotonic dystrophy type 1.
    Richards CS; Palomaki GE; Hegde M
    Genet Med; 2016 Dec; 18(12):1290-1294. PubMed ID: 27253733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a genomic DNA reference material panel for myotonic dystrophy type 1 (DM1) genetic testing.
    Kalman L; Tarleton J; Hitch M; Hegde M; Hjelm N; Berry-Kravis E; Zhou L; Hilbert JE; Luebbe EA; Moxley RT; Toji L
    J Mol Diagn; 2013 Jul; 15(4):518-25. PubMed ID: 23680132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myotonic dystrophy type 1: role of CCG, CTC and CGG interruptions within DMPK alleles in the pathogenesis and molecular diagnosis.
    Santoro M; Masciullo M; Silvestri G; Novelli G; Botta A
    Clin Genet; 2017 Oct; 92(4):355-364. PubMed ID: 27991661
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Visconti VV; Macrì E; D'Apice MR; Centofanti F; Massa R; Novelli G; Botta A
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetic and clinical characterization of myotonic dystrophy type 1 patients carrying variant repeats within DMPK expansions.
    Pešović J; Perić S; Brkušanin M; Brajušković G; Rakočević-Stojanović V; Savić-Pavićević D
    Neurogenetics; 2017 Dec; 18(4):207-218. PubMed ID: 28942489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-Based Prevalence of Myotonic Dystrophy Type 1 Using Genetic Analysis of Statewide Blood Screening Program.
    Johnson NE; Butterfield RJ; Mayne K; Newcomb T; Imburgia C; Dunn D; Duval B; Feldkamp ML; Weiss RB
    Neurology; 2021 Feb; 96(7):e1045-e1053. PubMed ID: 33472919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust and accurate detection and sizing of repeats within the DMPK gene using a novel TP-PCR test.
    Leferink M; Wong DPW; Cai S; Yeo M; Ho J; Lian M; Kamsteeg EJ; Chong SS; Haer-Wigman L; Guan M
    Sci Rep; 2019 Jun; 9(1):8280. PubMed ID: 31164682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Origin of the myotonic dystrophy type 1 mutation in Mexican population and influence of Amerindian ancestry on CTG repeat allelic distribution.
    Murillo-Melo NM; Márquez-Quiróz LC; Gómez R; Orozco L; Mendoza-Caamal E; Tapia-Guerrero YS; Camacho-Mejorado R; Cortés H; López-Reyes A; Santana C; Noris G; Hernández-Hernández O; Cisneros B; Magaña JJ
    Neuromuscul Disord; 2017 Dec; 27(12):1106-1114. PubMed ID: 29054426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a CCG-Enriched Expanded Allele in Patients with Myotonic Dystrophy Type 1 Using Amplification-Free Long-Read Sequencing.
    Tsai YC; de Pontual L; Heiner C; Stojkovic T; Furling D; Bassez G; Gourdon G; Tomé S
    J Mol Diagn; 2022 Nov; 24(11):1143-1154. PubMed ID: 36084803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fuchs' Endothelial Corneal Dystrophy in Patients With Myotonic Dystrophy, Type 1.
    Winkler NS; Milone M; Martinez-Thompson JM; Raja H; Aleff RA; Patel SV; Fautsch MP; Wieben ED; Baratz KH
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3053-3057. PubMed ID: 30025114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of 5' CCG interruptions in complex DMPK expanded alleles.
    Botta A; Rossi G; Marcaurelio M; Fontana L; D'Apice MR; Brancati F; Massa R; G Monckton D; Sangiuolo F; Novelli G
    Eur J Hum Genet; 2017 Feb; 25(2):257-261. PubMed ID: 27876818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of CTG repeats at the DMPK gene in myotonic dystrophy patients and healthy individuals from the Mexican population.
    Magaña JJ; Cortés-Reynosa P; Escobar-Cedillo R; Gómez R; Leyva-García N; Cisneros B
    Mol Biol Rep; 2011 Feb; 38(2):1341-6. PubMed ID: 20635151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technical standards and guidelines for myotonic dystrophy type 1 testing.
    Prior TW;
    Genet Med; 2009 Jul; 11(7):552-5. PubMed ID: 19546810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetics and genetic testing in myotonic dystrophy type 1.
    Savić Pavićević D; Miladinović J; Brkušanin M; Šviković S; Djurica S; Brajušković G; Romac S
    Biomed Res Int; 2013; 2013():391821. PubMed ID: 23586035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing.
    Izzo M; Battistini J; Provenzano C; Martelli F; Cardinali B; Falcone G
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual association of a unique CAG interruption in 5' of DM1 CTG repeats with intergenerational contractions and low somatic mosaicism.
    Tomé S; Dandelot E; Dogan C; Bertrand A; Geneviève D; Péréon Y; ; Simon M; Bonnefont JP; Bassez G; Gourdon G
    Hum Mutat; 2018 Jul; 39(7):970-982. PubMed ID: 29664219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo repeat interruptions are associated with reduced somatic instability and mild or absent clinical features in myotonic dystrophy type 1.
    Cumming SA; Hamilton MJ; Robb Y; Gregory H; McWilliam C; Cooper A; Adam B; McGhie J; Hamilton G; Herzyk P; Tschannen MR; Worthey E; Petty R; Ballantyne B; ; Warner J; Farrugia ME; Longman C; Monckton DG
    Eur J Hum Genet; 2018 Nov; 26(11):1635-1647. PubMed ID: 29967337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable Longitudinal Methylation Levels at the CpG Sites Flanking the CTG Repeat of
    Hildonen M; Knak KL; Dunø M; Vissing J; Tümer Z
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32823742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoblastoid cell lines derived from iPSCs of a myotonic dystrophy type 1 patient carrying 700 CTG repeats (CBRCULi007-A) and a control (CBRCULi006-A).
    Chahine M; Jauvin D; Pierre M; Puymirat J; Boutjdir M
    Stem Cell Res; 2023 Sep; 71():103148. PubMed ID: 37352653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Need for Establishing a Universal CTG Sizing Method in Myotonic Dystrophy Type 1.
    Ballester-Lopez A; Linares-Pardo I; Koehorst E; Núñez-Manchón J; Pintos-Morell G; Coll-Cantí J; Almendrote M; Lucente G; Arbex A; Magaña JJ; Murillo-Melo NM; Lucia A; Monckton DG; Cumming SA; Ramos-Fransi A; Martínez-Piñeiro A; Nogales-Gadea G
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32645888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.